Scrip’s Five Must-Know Things – 20 November 2023

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: AstraZeneca CEO on obesity and more; biotech’s rollercoaster ride set to continue; new Wegovy data; Novo’s plans for semaglutide in NASH; and Zepbound set to become biggest drug ever? https://scrip.citeline.com/SC149388/Quick-Listen-Scrips-Five-MustKnow-Things